Bengaluru: Govt and private quota seats for D-Pharma course will be allotted on merit through counselling conducted by Karnataka Examinations Authority (KEA) from academic year 2025-26, the govt said ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Royalty Pharma ( (RPRX)) has issued an ...

Dr. Makary is the commissioner of the Food and Drug Administration. Before joining the F.D.A., he was a surgeon at Johns Hopkins University School of Medicine. American drug advertisements are filled ...

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at Bernstein’s 2nd Annual Healthcare Forum on Tuesday, ...

In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Royalty Pharma plc is one of them. Royalty Pharma plc (NASDAQ:RPRX), a leader in biopharma ...

Special Report: LTR Pharma has co-founded and secured a 33% equity ownership in LevOmega, an Australian company focused on development of nature-identical omega-3 products. LevOmega has been ...

Roche ROG1.02%increase; green up pointing triangle Holding said it agreed to buy 89bio ETNB 0.07%increase; green up pointing triangle for up to $3.5 billion, seeking to bolster its drug pipeline by ...

This work presents valuable new data on the role of D-Serine and how it competes with its stereoisomer L-Serine to influence metabolism. The work presents a variety of solid experimental data combined ...

The U.K.-based AstraZeneca Plc (NASDAQ:AZN) paused a planned 200 million pounds ($271.26 million) investment in its Cambridge research site. AstraZeneca spokesperson told Reuters the company regularly ...

Drugmaker GSK has announced a £22billion investment in the US to coincide with Donald Trump's state visit to the UK. The London-listed pharmaceuticals giant said it would invest $30billion in research ...